Q1 2018
Released May 7, 2018, before the open
10-Q filed May 7, 2018, 37 days after period end · 0001144204-18-025522
Q1 2018 · 10-Q
Revenue$428.03K$428.03K — vs Q1 2017no prior Q4 2017 on file
Net Income-$2.72M-$2.72M N/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$0.13-$0.13 N/M vs Q1 2017N/M vs Q4 2017
Operating Income-$2,636,986N/M
Operating Cash Flow-$3,746,211N/M
Margins · derived
Operating margin-616.1%
Net margin-635.5%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $428.03K | $0.00 | — | — |
| Net Income | -$2.72M | -$4.86M | -$7.01M | -$2.96M |
| EPS Diluted | -$0.13 | -$0.26 | -$0.38 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR